Larvol Delta - AMB05X--ab-against-CSF1R-in-tenosynovial-giant-cell-tumor-TGCT--preliminary-results-presented-at-CTOS2022--128312significant-improvement-in-almost-all-Quality-of-life-measures-TGCTSupportorg-CTOSTweeTOS

AMB-05X - AmMax

Nov 18, 2022